Form 4: Hinge Health CEO Sells Shares
Insider Transaction (Form 4)
Daniel Antonio Perez, CEO & Co-Founder, a Director and 10% owner of Hinge Health, Inc., sold 250,000 shares of common stock on September 10, 2026.
Summary
- Conversion of derivative: acquired 145,000 Class A Common Stock on September 10, 2026; holds 145,000 after (Direct).
- Open-market sale: disposed of 24,390 Class A Common Stock at $88.22 ($2,151,727) on September 10, 2026; holds 120,610 after (Direct).
- Open-market sale: disposed of 24,599 Class A Common Stock at $89.02 ($2,189,783) on September 10, 2026; holds 96,011 after (Direct).
- Open-market sale: disposed of 42,740 Class A Common Stock at $90.09 ($3,850,494) on September 10, 2026; holds 53,271 after (Direct).
- Open-market sale: disposed of 7,171 Class A Common Stock at $90.95 ($652,183) on September 10, 2026; holds 46,100 after (Direct).
- Open-market sale: disposed of 1,100 Class A Common Stock at $91.60 ($100,759) on September 10, 2026; holds 45,000 after (Direct).
- Bona fide gift: disposed of 45,000 Class A Common Stock on September 10, 2026 (Direct).
- Conversion of derivative: acquired 150,000 Class A Common Stock on September 10, 2026; holds 185,470 after (Indirect).
- Open-market sale: disposed of 37,251 Class A Common Stock at $88.22 ($3,286,145) on September 10, 2026; holds 148,219 after (Indirect).
- Open-market sale: disposed of 35,303 Class A Common Stock at $89.01 ($3,142,341) on September 10, 2026; holds 112,916 after (Indirect).
- Open-market sale: disposed of 58,076 Class A Common Stock at $90.03 ($5,228,757) on September 10, 2026; holds 54,840 after (Indirect).
- Open-market sale: disposed of 17,740 Class A Common Stock at $90.76 ($1,610,146) on September 10, 2026; holds 37,100 after (Indirect).
- Open-market sale: disposed of 1,630 Class A Common Stock at $91.60 ($149,308) on September 10, 2026; holds 35,470 after (Indirect).
- Conversion of derivative: disposed of 145,000 Class B Common Stock on September 10, 2026; holds 9,778,672 after (Direct).
- Conversion of derivative: disposed of 150,000 Class B Common Stock on September 10, 2026; holds 208,445 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $22,361,643 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Daniel Antonio Perez — Director, Officer (CEO & Co-Founder), 10% owner
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Conversion of derivative | Class A Common Stock | 145,000 | — | — | 145,000 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 24,390 | $88 | $2.2M | 120,610 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 24,599 | $89 | $2.2M | 96,011 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 42,740 | $90 | $3.9M | 53,271 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 7,171 | $91 | $652.2K | 46,100 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 1,100 | $92 | $100.8K | 45,000 |
| 2026-09-10 | Bona fide gift | Class A Common Stock | 45,000 | — | — | 0 |
| 2026-09-10 | Conversion of derivative | Class A Common Stock | 150,000 | — | — | 185,470 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 37,251 | $88 | $3.3M | 148,219 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 35,303 | $89 | $3.1M | 112,916 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 58,076 | $90 | $5.2M | 54,840 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 17,740 | $91 | $1.6M | 37,100 |
| 2026-09-10 | Open-market sale | Class A Common Stock | 1,630 | $92 | $149.3K | 35,470 |
| 2026-09-10 | Conversion of derivative | Class B Common Stock | 145,000 | — | — | 9,778,672 |
| 2026-09-10 | Conversion of derivative | Class B Common Stock | 150,000 | — | — | 208,445 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Conversion of derivative (145,000 shares) |
| 2026-09-10 | Open-market sale (24,390 shares) |
| 2026-09-10 | Open-market sale (24,599 shares) |
| 2026-09-10 | Open-market sale (42,740 shares) |
| 2026-09-10 | Open-market sale (7,171 shares) |
| 2026-09-10 | Open-market sale (1,100 shares) |
| 2026-09-10 | Bona fide gift (45,000 shares) |
| 2026-09-10 | Conversion of derivative (150,000 shares) |
| 2026-09-10 | Open-market sale (37,251 shares) |
| 2026-09-10 | Open-market sale (35,303 shares) |
| 2026-09-10 | Open-market sale (58,076 shares) |
| 2026-09-10 | Open-market sale (17,740 shares) |
| 2026-09-10 | Open-market sale (1,630 shares) |
| 2026-09-10 | Conversion of derivative (145,000 shares) |
| 2026-09-10 | Conversion of derivative (150,000 shares) |
Keywords
insider transaction, Form 4, HNGE, Hinge Health, Inc., bearish, Daniel Antonio Perez
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.